Literature DB >> 17534364

'Unleashed' natural killers hinder HIV.

Marcus Altfeld, Philip Goulder.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17534364     DOI： 10.1038/ng0607-708

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  20 in total

1.  Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection.

Authors:  Caroline T Tiemessen; Sharon Shalekoff; Stephen Meddows-Taylor; Diana B Schramm; Maria A Papathanasopoulos; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

Review 2.  DCs and NK cells: critical effectors in the immune response to HIV-1.

Authors:  Marcus Altfeld; Lena Fadda; Davor Frleta; Nina Bhardwaj
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 3.  HIV and HLA class I: an evolving relationship.

Authors:  Philip J R Goulder; Bruce D Walker
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

4.  HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C∗12:02/C∗14:03.

Authors:  Zhansong Lin; Kimiko Kuroki; Nozomi Kuse; Xiaoming Sun; Tomohiro Akahoshi; Ying Qi; Takayuki Chikata; Takuya Naruto; Madoka Koyanagi; Hayato Murakoshi; Hiroyuki Gatanaga; Shinichi Oka; Mary Carrington; Katsumi Maenaka; Masafumi Takiguchi
Journal:  Cell Rep       Date:  2016-11-22       Impact factor: 9.423

5.  Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.

Authors:  Philippa C Matthews; Madoka Koyanagi; Henrik N Kløverpris; Mikkel Harndahl; Anette Stryhn; Tomohiro Akahoshi; Hiroyuki Gatanaga; Shinichi Oka; Claudia Juarez Molina; Humberto Valenzuela Ponce; Santiago Avila Rios; David Cole; Jonathan Carlson; Rebecca P Payne; Anthony Ogwu; Alfred Bere; Thumbi Ndung'u; Kamini Gounder; Fabian Chen; Lynn Riddell; Graz Luzzi; Roger Shapiro; Christian Brander; Bruce Walker; Andrew K Sewell; Gustavo Reyes Teran; David Heckerman; Eric Hunter; Søren Buus; Masafumi Takiguchi; Philip J R Goulder
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

6.  Impact of HLA Allele-KIR Pairs on HIV Clinical Outcome in South Africa.

Authors:  Masahiko Mori; Ellen Leitman; Bruce Walker; Thumbi Ndung'u; Mary Carrington; Philip Goulder
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

7.  Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection.

Authors:  Christina F Thobakgale; Andrew Prendergast; Hayley Crawford; Nompumelelo Mkhwanazi; Danni Ramduth; Sharon Reddy; Claudia Molina; Zenele Mncube; Alasdair Leslie; Julia Prado; Fundi Chonco; Wendy Mphatshwe; Gareth Tudor-Williams; Prakash Jeena; Natasha Blanckenberg; Krista Dong; Photini Kiepiela; Hoosen Coovadia; Thumbi Ndung'u; Bruce D Walker; Philip J R Goulder
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

8.  HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.

Authors:  Galit Alter; Suzannah Rihn; Katharine Walter; Anne Nolting; Maureen Martin; Eric S Rosenberg; Jeffrey S Miller; Mary Carrington; Marcus Altfeld
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

Review 9.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

10.  Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102: a bioinformatic approach to the prediction of new epitopes.

Authors:  Valerie A Walshe; Channa K Hattotuwagama; Irini A Doytchinova; Mailee Wong; Isabel K Macdonald; Arend Mulder; Frans H J Claas; Pierre Pellegrino; Jo Turner; Ian Williams; Emma L Turnbull; Persephone Borrow; Darren R Flower
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.